Active Ingredient: Bismuth subnitrate 2.6g per 4g syringe
Indications: Boviseal is indicated for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of subclinical mastitis in cows at calving, and of clinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving). It is recommended that Boviseal be used as part of a herd approach to dry cow management and mastitis control.
Dosage: 1 syringe per quarter.